90-Year-Old Cyclist Stripped Of World Record After Failing Anti-Doping Test
credits: Brynn Lennon | source: Getty Last July, 90-year-old cyclist Carl Grove was the lone competitor in his age group at the U.S. Masters Track Championships, where he set an age-group world record in the individual pursuit with a time of 3:06:129. Sadly, Grove subsequently popped a positive for the banned steroid epitrenbolone in a drug test after the race. Now, even though the U.S. Anti-Doping Agency let Grove off with a public warning, he has been stripped of his world record.
According to a USADA release, Grove came up hot for epitrenbolone, as well as clomiphene. Grove handed over his supplements to USADA, and they determined that the clomiphene was a contaminant in a legal supplement he was taking. As for the epitrenbolone, Grove was negative on a test the day before his race, when he won gold in men’s 90-94 time trial as the only competitor. Because of that, USADA believes the positive test was “more likely than not caused by contaminated meat.”
Grove won’t be suspended, though the timing of the test cost him his record:
Since his positive sample was collected in-competition, Grove has been disqualified from competitive results obtained on July 11, 2018, the date his sample was collected.
At least Grove’s national masters championships in the time trial and sprint will stand. He’ll be able to try to get his world record back this year.
How Gary Bettman Built the Model MLB Owners Crave
UFC 325 Betting Preview: Three Bet Picks for Saturday Night
Three Trades the NBA Needs to Make Before the Deadline
- Rangers vs Islanders Jan. 28 NHL Betting Pick and Predictions
- College Basketball Picks Today: Nebraska vs. Michigan Headlines Loaded Slate
- Tuesday NHL Betting Picks: Expert Bets for Jan. 27th
- Best NBA Bets Today: Spread Picks and Player Props for Monday’s Games
- NFL Championship Weekend Picks: AFC & NFC Best Bets
- College Basketball Player Prop Bet Picks for Saturday, January 24th
- UFC 324 Preview and Best Bets: Sean O’Malley, and More

